A Decade of Advances in Treatment of Early-Stage Lung Cancer

Clinics in Chest Medicine

Volumn 32, Issue 4, 2011, Pages 827-838

  Paoletti, Luca ^a   Pastis, Nicholas J ^a   Denlinger, Chadrick E ^b   Silvestri, Gerard A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Elderly; Lung cancer; Surgery; Treatment; VATS

Indexed keywords

CISPLATIN; NAVELBINE;

ADJUVANT THERAPY; AGING; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; EARLY CANCER; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SMALL CELL CANCER; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEREOTACTIC BODY RADIATION THERAPY; SUBLOBAR RESECTION; TUMOR VOLUME; VIDEO ASSISTED THORACOSCOPIC SURGERY;

AGE FACTORS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PNEUMONECTOMY; SURVIVAL RATE; THORACIC SURGERY, VIDEO-ASSISTED;

EID: 80555136679     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2011.08.009     Document Type: Review

References (92)

1. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 1997, 111(6):1710-1717.
2. Pairolero P.C., Williams D.E., Bergstralh E.J., et al. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 1984, 38(4):331-338.
3. Feld R., Rubinstein L.V., Weisenberger T.H. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol 1984, 2(12):1352-1358.
4. Goldstraw P., Crowley J., Chansky K., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2(8):706-714.
5. Scott W.J., Howington J., Feigenberg S., et al. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132(Suppl 3):234S-242S.
6. Jemal A., Siegel R., Xu J., et al. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300.
7. The National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365(5):395-409. [Epub ahead of print].
8. Strauss G.M., Herndon J.E., Maddaus M.A., et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 2008, 26(31):5043-5051.
9. Graham E.A. The first total pneumonectomy. Tex Cancer Bull 1949, 2(1):2-4.
10. Paul S., Port J. Limited resection for non-small cell lung cancer. Chest Physician 2010, 5(6):13-14.
11. Narsule C.K., Ebright M.I., Fernando H.C. Sublobar versus lobar resection: current status. Cancer J 2011, 17(1):23-27.
12. Ginsberg R.J., Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995, 60(3):615-622. [discussion: 622-23].
13. Chang M.Y., Mentzer S.J., Colson Y.L., et al. Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2007, 134(4):850-856.
14. El-Sherif A., Gooding W.E., Santos R., et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006, 82(2):408-415. [discussion: 415-16].
15. Errett L.E., Wilson J., Chiu R.C., et al. Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients. J Thorac Cardiovasc Surg 1985, 90(5):656-661.
16. Pastorino U., Valente M., Bedini V., et al. Limited resection for Stage I lung cancer. Eur J Surg Oncol 1991, 17(1):42-46.
17. Miller D.L., Rowland C.M., Deschamps C., et al. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg 2002, 73(5):1545-1550. [discussion: 1550-51].
18. Kondo D., Yamada K., Kitayama Y., et al. Peripheral lung adenocarcinomas: 10 mm or less in diameter. Ann Thorac Surg 2003, 76(2):350-355.
19. Schuchert M.J., Pettiford B.L., Keeley S., et al. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg 2007, 84(3):926-932. [discussion: 932-933].
20. Okada M., Nishio W., Sakamoto T., et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg 2005, 129(1):87-93.
21. Landreneau R.J., Sugarbaker D.J., Mack M.J., et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. J Thorac Cardiovasc Surg 1997, 113(4):691-698. [discussion 698-700].
22. Sienel W., Dango S., Kirschbaum A., et al. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections. Eur J Cardiothorac Surg 2008, 33(4):728-734.
23. El-Sherif A., Fernando H.C., Santos R., et al. Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol 2007, 14(8):2400-2405.
24. Sawabata N., Ohta M., Matsumura A., et al. Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study. Ann Thorac Surg 2004, 77(2):415-420.
25. Warren W.H., Faber L.P. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg 1994, 107(4):1087-1093. [discussion: 1093-94].
26. Campione A., Ligabue T., Luzzi L., et al. Comparison between segmentectomy and larger resection of stage IA non-small cell lung carcinoma. J Cardiovasc Surg (Torino) 2004, 45(1):67-70.
27. Martini N., Bains M.S., Burt M.E., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995, 109(1):120-129.
28. Kates M., Swanson S., Wisnivesky J.P. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer <1 cm in size: a review of SEER data. Chest 2011, 139(3):491-496.
29. McKenna R.J., Houck W., Fuller C.B. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006, 81(2):421-425. [discussion: 425-6].
30. Sugi K., Kaneda Y., Esato K. Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J Surg 2000, 24(1):27-30. [discussion: 30-1].
31. Koizumi K., Haraguchi S., Hirata T., et al. Video-assisted lobectomy in elderly lung cancer patients. Jpn J Thorac Cardiovasc Surg 2002, 50(1):15-22.
32. Sakuraba M., Miyamoto H., Oh S., et al. Video-assisted thoracoscopic lobectomy vs. conventional lobectomy via open thoracotomy in patients with clinical stage IA non-small cell lung carcinoma. Interact Cardiovasc Thorac Surg 2007, 6(5):614-617.
33. Yamamoto K., Ohsumi A., Kojima F., et al. Long-term survival after video-assisted thoracic surgery lobectomy for primary lung cancer. Ann Thorac Surg 2010, 89(2):353-359.
34. Shigemura N., Akashi A., Funaki S., et al. Long-term outcomes after a variety of video-assisted thoracoscopic lobectomy approaches for clinical stage IA lung cancer: a multi-institutional study. J Thorac Cardiovasc Surg 2006, 132(3):507-512.
35. Yan T.D., Black D., Bannon P.G., et al. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol 2009, 27(15):2553-2562.
36. Farjah F., Wood D.E., Mulligan M.S., et al. Safety and efficacy of video-assisted versus conventional lung resection for lung cancer. J Thorac Cardiovasc Surg 2009, 137(6):1415-1421.
37. Inada K., Shirakusa T., Yoshinaga Y., et al. The role of video-assisted thoracic surgery for the treatment of lung cancer: lung lobectomy by thoracoscopy versus the standard thoracotomy approach. Int Surg 2000, 85(1):6-12.
38. Sagawa M., Sato M., Sakurada A., et al. A prospective trial of systematic nodal dissection for lung cancer by video-assisted thoracic surgery: can it be perfect?. Ann Thorac Surg 2002, 73(3):900.
39. Kirby T.J., Mack M.J., Landreneau R.J., et al. Lobectomy-video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial. J Thorac Cardiovasc Surg 1995, 109(5):997-1001. [discussion: 1001-2].
40. Handy J.R., Asaph J.W., Douville E.C., et al. Does video-assisted thoracoscopic lobectomy for lung cancer provide improved functional outcomes compared with open lobectomy?. Eur J Cardiothorac Surg 2010, 37(2):451-455.
41. Ohbuchi T., Morikawa T., Takeuchi E., et al. Lobectomy: video-assisted thoracic surgery versus posterolateral thoracotomy. Jpn J Thorac Cardiovasc Surg 1998, 46(6):519-522.
42. Scott W.J., Allen M.S., Darling G., et al. Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial. J Thorac Cardiovasc Surg 2010, 139(4):976-981. [discussion 981-3].
43. Swanson S.J., Herndon J.E., D'Amico T.A., et al. Video-assisted thoracic surgery lobectomy: report of CALGB 39802-a prospective, multi-institution feasibility study. J Clin Oncol 2007, 25(31):4993-4997.
44. Nagahiro I., Andou A., Aoe M., et al. Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure. Ann Thorac Surg 2001, 72(2):362-365.
45. Petersen R.P., Pham D., Burfeind W.R., et al. Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer. Ann Thorac Surg 2007, 83(4):1245-1249. [discussion: 1250].
46. Yim A.P., Landreneau R.J., Izzat M.B., et al. Is video-assisted thoracoscopic lobectomy a unified approach?. Ann Thorac Surg 1998, 66(4):1155-1158.
47. Boffa D.J., Allen M.S., Grab J.D., et al. Data from the society of thoracic surgeons general thoracic surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg 2008, 135(2):247-254.
48. Goodney P.P., Lucas F.L., Stukel T.A., et al. Surgeon specialty and operative mortality with lung resection. Ann Surg 2005, 241(1):179-184.
49. Silvestri G.A., Handy J., Lackland D., et al. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest 1998, 114(3):675-680.
50. Schipper P.H., Diggs B.S., Ungerleider R.M., et al. The influence of surgeon specialty on outcomes in general thoracic surgery: a national sample 1996 to 2005. Ann Thorac Surg 2009, 88(5):1566-1572. [discussion 1572-73].
51. Bach P.B., Cramer L.D., Schrag D., et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001, 345(3):181-188.
52. Lyons G., Quadrelli S., Silva C., et al. Analysis of survival in 400 surgically resected non-small cell lung carcinomas: towards a redefinition of the T factor. J Thorac Oncol 2008, 3(9):989-993.
53. Pelletier M.P., Edwardes M.D., Michel R.P., et al. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg 2001, 44(3):180-188.
54. Strauss G.M. Prognostic markers in resectable non-small cell lung cancer. Hematol Oncol Clin North Am 1997, 11(3):409-434.
55. International union against cancer. Lung tumours. TNM classification of malignant tumors 2002, 103. Wiley-Liss, New York. L. Sobin, C. Wittekind (Eds.).
56. Carbone E., Asamura H., Takei H., et al. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer. J Thorac Cardiovasc Surg 2001, 122(5):907-912.
57. Naruke T., Tsuchiya R., Kondo H., et al. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 2001, 71(6):1759-1764.
58. Mery C.M., Pappas A.N., Bueno R., et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005, 128(1):237-245.
59. Sawada S., Komori E., Nogami N., et al. Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical condition. Chest 2005, 128(3):1557-1563.
60. Zapatero J., Flandes J., Salvatierra S., et al. Thoracotomy in patients over 70 years old. Monaldi Arch Chest Dis 1994, 49(4):298-301.
61. Okami J., Ito Y., Higashiyama M., et al. Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer. Ann Thorac Surg 2010, 90(5):1651-1656.
62. Ikeda N., Hayashi A., Iwasaki K., et al. Surgical strategy for non-small cell lung cancer in octogenarians. Respirology 2007, 12(5):712-718.
63. Brokx H.A., Visser O., Postmus P.E., et al. Surgical treatment for octogenarians with lung cancer: results from a population-based series of 124 patients. J Thorac Oncol 2007, 2(11):1013-1017.
64. Alberts W.M. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:1S-19S.
65. Govindan R., Page N., Morgensztern D., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006, 24(28):4539-4544.
66. Shepherd F.A. Surgery for limited stage small cell lung cancer: time to fish or cut bait. J Thorac Oncol 2010, 5(2):147-149.
67. Schreiber D., Rineer J., Weedon J., et al. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?. Cancer 2010, 116(5):1350-1357.
68. Simon G.R., Turrisi A., American College of Chest Physicians Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132(Suppl 3):324S-339S.
69. Yu J.B., Decker R.H., Detterbeck F.C., et al. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol 2010, 5(2):215-219.
70. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995, 311(7010):899-909.
71. Pignon J.P., Tribodet H., Scagliotti G.V., et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008, 26(21):3552-3559.
72. Douillard J.Y., Rosell R., De Lena M., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006, 7(9):719-727.
73. Winton T., Livingston R., Johnson D., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005, 352(25):2589-2597.
74. Arriagada R., Bergman B., Dunant A., et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004, 350(4):351-360.
75. Pisters K.M., Evans W.K., Azzoli C.G., et al. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 2007, 25(34):5506-5518.
76. Bach P.B., Cramer L.D., Warren J.L., et al. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999, 341(16):1198-1205.
77. Wisnivesky J.P., Bonomi M., Henschke C., et al. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 2005, 128(3):1461-1467.
78. Fakiris A.J., McGarry R.C., Yiannoutsos C.T., et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009, 75(3):677-682.
79. Qiao X., Tullgren O., Lax I., et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003, 41(1):1-11.
80. Powell J.W., Dexter E., Scalzetti E.M., et al. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials. Lancet Oncol 2009, 10(9):885-894.
81. Rowell N.P., Williams C.J. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax 2001, 56(8):628-638.
82. Nguyen N.P., Garland L., Welsh J., et al. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma. Cancer Treat Rev 2008, 34(8):719-727.
83. Timmerman R., Paulus R., Galvin J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303(11):1070-1076.
84. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006, 24(30):4833-4839.
85. Onishi H., Shirato H., Nagata Y., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2(7 Suppl 3):S94-S100.
86. Onishi H., Shirato H., Nagata Y., et al. Stereotactic Body Radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?. Int J Radiat Oncol Biol Phys 2010, [Epub ahead of print].
87. Lencioni R., Crocetti L., Cioni R., et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008, 9(7):621-628.
88. Gewanter R.M., Rosenzweig K.E., Chang J.Y., et al. ACR Appropriateness Criteria: nonsurgical treatment for non-small-cell lung cancer: good performance status/definitive intent. Curr Probl Cancer 2010, 34(3):228-249.
89. Steinke K., Sewell P.E., Dupuy D., et al. Pulmonary radiofrequency ablation-an international study survey. Anticancer Res 2004, 24(1):339-343.
90. Lanuti M., Sharma A., Digumarthy S.R., et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2009, 137(1):160-166.
91. Gomez F.M., Palussiere J., Santos E., et al. Radiofrequency thermocoagulation of lung tumours. Where we are, where we are headed. Clin Transl Oncol 2009, 11(1):28-34.
92. Blasberg J.D., Pass H.I., Donington J.S. Sublobar resection: a movement from the Lung Cancer Study Group. J Thorac Oncol 2010, 5(10):1583-1593.